People · Operator

Martha Sue Preston

Named in public records as an officer, director or promoter · active 2013–2017 · Biotechnology

2
Companies
3
Filings
$7.0M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
BioAesthetics CorpBiotechnologySeries A$6.9M$211.1M2017
MiniVax, Inc.BiotechnologyPre-Seed$110K$6.1M2013
Operator network

Martha Sue Preston at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Sandra Coufal · 3 companies · 1 sharedSandra CoufalSandra I. Coufal · 2 companies · 1 sharedSandra I. CoufalM. Sue Preston · 1 companies · 1 sharedM. Sue PrestonNicholas C. Pashos · 1 companies · 1 sharedNicholas C. PashosNicholas Pashos · 1 companies · 1 sharedNicholas PashosWilliam M. Heim · 1 companies · 1 sharedWilliam M. HeimWilliam Sue Heim · 1 companies · 1 sharedWilliam Sue HeimYi Sue Gu · 1 companies · 1 sharedYi Sue GuA. Ray Chaudhuri · 1 companies · 1 sharedA. Ray ChaudhuriDouglas Sue Carnes · 1 companies · 1 sharedDouglas Sue CarnesMartin Sue Preuveneers · 1 companies · 1 sharedMartin Sue Preuve…Sandra Sue Coufal · 1 companies · 1 sharedSandra Sue CoufalBioAesthetics Corp · $6.9M raisedBioAesthetics CorpMiniVax, Inc. · $0.1M raisedMiniVax, Inc.Martha Sue PrestonMP
Martha Sue Preston Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Martha Sue Preston on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Sandra Coufal13
Sandra I. Coufal12
M. Sue Preston11
Nicholas C. Pashos11
William M. Heim11
Nicholas Pashos11
William Sue Heim11
Martin Sue Preuveneers11
Sandra Sue Coufal11
A. Ray Chaudhuri11
Douglas Sue Carnes11
Yi Sue Gu11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.